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Abstract
Background:  Malignant melanoma of the conjunctiva is an extremely rare non-cutaneous
neoplasm with infrequent skeletal metastatic spread.
Case presentation: We present the case of a 54 year old female Caucasian patient with osseous
metastases originating from a malignant melanoma of her right conjunctiva. Metastatic deposits
were identified in the left humeral diaphysis and left tibial metaphysis. Clinical, radiological and
scintigraphic evaluation necessitated prompt stabilisation of both long bones. Following reamed
intramedullary nailing and post-operative radiotherapy she remains asymptomatic six months post-
operatively.
Conclusion:  This unusual pattern of metastatic spread to the appendicular skeleton of an
extremely rare melanomatous lesion requires diagnostic vigilance as well as a multidisciplinary
approach for accurate diagnosis, staging and management. Due to the poor prognosis, treatment
goals should be directed to palliation of symptoms and prolongation of the quality of life.
Introduction
Malignant melanoma of the conjunctiva is a rare extraoc-
ular neoplasm. Its incidence is reported to be 0.2–0.8 per
million in white populations and represents 1.6% of all
non-cutaneous melanomas [1].
Although the potential metastastic spread of conjunctival
melanoma to bone has been recognized [2], the available
literature does not accurately specify the exact skeletal
sites and number of patients affected. Most of the infor-
mation about melonomatous spread to bone derives from
studies concentrated on the cutaneous type with a
reported incidence of 7 – 17% [3-5], tendency for spread
to the axial skeleton [3,4] and a mean survival of 3.6 – 8
months [3,4,6] despite treatment.
A case of metastatic spread of malignant conjunctival
melanoma to the appendicular skeleton is presented.
Case report
A 54 year old female Caucasian patient presented to the
orthopaedic outpatient clinic complaining of left arm and
left knee pain. She had been diagnosed with malignant
melanoma of the palpebral and forniceal conjunctiva 2.5
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years before and had received treatment at the regional
ocular oncology centre in the form of surgical excision,
cryotherapy and adjuvant Mitomycin C.
During her oncological follow up 30 months following
the original diagnosis, multiple bilateral pulmonary
metastases all measuring <0.5 cms in diameter as well as
a 4 × 2 cm right ischial lesion were identified. She was
complaining of left arm and left knee pain and was there-
fore referred to the orthopaedic clinic.
The pattern of the pain was constant with occasional noc-
turnal exacerbations and was aggravated by weight bear-
ing activities of both extremities. Clinical examination
demonstrated localized areas of tenderness over the mid-
shaft area of the left humerus as well as over the anterome-
dial aspect of the left proximal tibia. Furthermore a non-
fluctuant swelling measuring 2 × 2 centimeters in diame-
ter was palpable over the corresponding left proximal tib-
ial metaphysis. All neighbouring joints examined normal.
Her right ischial lesion was asymptomatic.
Radiographic evaluation demonstrated lytic lesions of the
left humeral diaphysis and proximal tibial metaphysis
with associated cortical involvement and ill defined zones
of transition, however no evidence of fracture (Figure 1).
A bone scan confirmed the presence of three active areas
corresponding to the lucent radiographic areas of the left
humerus, left tibia and right ischium. It did not identify
any further skeletal lesions
Regarding her osseous lesions she underwent intramedul-
lary nailing procedures of both long bones on a semi-elec-
tive basis due to the danger of impending fracture.
According to the Mirels classification for metastatic bone
disease at risk of fracture, [7] she scored 9 points for the
humerus and 10 for the tibia.
A standard reamed and locked nailing technique was
applied for stabilization of both bones with no associated
intra-operative complications (Figure 2). Venting of both
bones was performed during the procedure in an attempt
to reduce intra-osseous pressure and prevent the risk of fat
and tumour embolisation. Intramedullary reamings, as
well as specimens obtained via open curettage of the radi-
ologically suspect lesions were sent to the histopathology
department.
The patient had an uneventful recovery and was dis-
charged home within 4 days. Histological examination
confirmed the presence of devitalized bone and exten-
sively necrotic, heavily pigmented epithelioid tumour,
consistent with a diagnosis of metastatic malignant
melanoma. There was a low mitotic count (1/mm2) and
no significant lymphocytic infiltrate (Figure 3).
At her latest follow up visit in the orthopaedic clinic 6
months post-operatively, she remains pain-free with no
radiographic evidence of further metastatic spread of the
involved bones. Further oncological input consisted of
palliative radiotherapy to her right ischial and left
humeral lesions, as well as bisphosphonate administra-
tion. No conjunctival recurrence has been identified 3
years following the original diagnosis.
Discussion
Malignant melanoma of the conjunctiva is a potentially
lethal neoplasm with an average 10 year mortality rate of
30% [2]. Tumours located in the palpebral and forniceal
conjunctival regions are infrequent (incidence of 4% and
Pre-operative radiographs of the left humerus and left knee  demonstrating osteolytic lesions eroding the cortex Figure 1
Pre-operative radiographs of the left humerus and 
left knee demonstrating osteolytic lesions eroding 
the cortex.
Post-operative radiographs demonstrating stabilized left  humerus and left tibia with intramedullary nails Figure 2
Post-operative radiographs demonstrating stabilized 
left humerus and left tibia with intramedullary nails.Cases Journal 2009, 2:125 http://www.casesjournal.com/content/2/1/125
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3% respectively) and are associated with a worse progno-
sis [1], however the extent of the disease at time of presen-
tation is the most important factor in determining
outcome. The conjunctival stroma contains blood vessels
and lymphatics thus local and systemic metastases can
occur [2]. Regional lymph node involvement usually
occurs first, however systemic dissemination without pre-
vious lymphatic spread can take place [2].
Osseous metastases occur in patients with advanced pri-
mary and multiple lesions. They generally exhibit a predi-
lection to spread in the axial skeleton with an incidence of
70–86% [3,4]. This can be partly explained by red marrow
predominance in the axial skeleton and a unique vascular
venous network anastomosing the pelvis to the spine,
resulting in an increased likelihood of seeding [6]. Metas-
tases to the appendicular skeleton occur infrequently and
when isolated they are associated with a three fold
increased survival [6]. The melanocytes produce factors
that stimulate osteoclasts, stromal cells and macrophages
to release osteotropic cytokines such as Interleukin-6 (IL-
6), Prostaglandin E2 (PGE2) and Transforming Growth
Factor alpha (TGF-α) [8]. Osseous metastases are gener-
ally osteolytic, eccentric and oval, provoking little if any
periosteal response [3,4]. They first involve the medullary
cavity or trabeculae and proceed to cortical erosion, lead-
ing to pathological fractures, bone marrow failure and
neurological deficits.
In trying to establish the presence of metastatic spread of
conjunctival melanoma for staging purposes, several
methods are available. Magnetic Resonance Imaging
(MRI) of the head is a useful tool in assessing for orbital
or other regional spread. The latter can also be detected by
sentinel lymph node excision biopsy which offers the
potential for both earlier diagnosis and provision of adju-
vant therapies [2].
Osseous metastases can be identified by several imaging
methods. The features of melanomatous lesions on plain
radiographs have already been discussed. Bone scintigra-
phy is more sensitive in being able to detect more lesions
and earlier [3]. Although computed tomography (CT) can
identify skeletal metastases, MRI can also assess soft tissue
extent and can influence treatment, despite its cost [5].
Positron emission tomography CT can be useful for the
follow up and restaging of conjunctival melanoma; how-
ever its use in initial staging is limited [9].
In the present case two symptomatic osteolytic metastatic
foci were identified in the humeral diaphysis and proxi-
mal tibial metaphysis. There were signs of cortical erosion
which threatened impending pathological fractures of
both long bones, according to the Mirels scoring system
[7]. Although previous recommendations favoured the
use of palliative fixation for unstable pathological frac-
tures [4], intramedullary nailing facilitates stabilization of
the whole bone, which is mandatory for prophylaxis
against impending fractures [10]. Venting during prophy-
lactic reamed nailing, reduces pressurization of the canal,
therefore this technique was used as a measure against fat
and tumour embolisation [11]. The use of reamings as
histological specimens is not supported in the literature,
as bone sampling can be destructive, making diagnosis
difficult and unreliable, therefore they should be accom-
panied by biopsies, as was done in this case [12].
The presence of multiple foci to the skeleton and lungs
precluded metastasectomy as this would have been asso-
ciated with significant morbidity [13]. Adjuvant therapeu-
tic regimens were limited to the use of radiotherapy of the
ischial and humeral lesions as well as bisphosphonate
administration. Radiotherapy prevents local recurrence
and provides palliation, despite previous concerns regard-
ing radioresistance of malignant melanoma [14]. Further-
more it has been reported that appendicular metastases
respond better. Bisphosphonates induce apoptosis in
human melanoma cells, can reduce bone pain, and can
inhibit osteoclast activity [15]. Systemic chemotherapy,
biochemotherapy and immunotherapy can be used; how-
ever survival as well as control of lesion growth and pain
is generally not improved [4]. Isolated limb perfusion
chemotherapy can achieve symptomatic and radiologic
control, however it was not used in this case[13]
Histological section of biopsy Figure 3
Histological section of biopsy. Original magnification 
×200, H&E stain showing strands of focally pigmented pleo-
morphic epithelioid cells in decalcified sections of bone. Fea-
tures are fully consistent with metastatic melanoma.Publish with BioMed Central    and   every 
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Conclusion
Malignant melanoma of the conjunctiva is an extremely
rare neoplasm. Palbebral and forniceal involvement,
although uncommon, can be associated with poorer prog-
nosis and survival. Systemic spread to the skeleton and
particularly the long bones of the extremities, without pre-
vious regional lymphatic involvement, adds to the infre-
quency of occurrence and undermines the prognosis of
the herein presented case.
In the presence of impending pathological fractures,
osseous surgical stabilization followed by adjuvant thera-
pies should be offered in an attempt to improve the
patient's quality of life. Combined input from the opthal-
mological, oncological, radiological, histopathological
and orthopaedic disciplines is required for accurate diag-
nosis, staging and management.
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